跳至主要内容
临床试验/NCT05177354
NCT05177354已完成不适用

Evaluation of Long-term Patient Experience With a Medtronic Closed-Loop Spinal Cord Stimulation System

MedtronicNeuro14 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2021年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
94
试验地点
14
主要终点
Reduction in Overstimulation Sensation

研究概览

简要总结

The purpose of the study is to further understand the closed-loop feature in chronically implanted patients by characterizing the efficacy of the next generation, spinal cord stimulator.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of the trunk and/or limbs
  • If being treated for low-back and/or leg pain,
  • the baseline overall^ Visual Analog Scale is ≥ 60 mm and
  • baseline back and/or leg pain Visual Analog Scale is ≥60 mm. ^Average overall pain in the back and/or leg in the 72 hours prior to the baseline visit, measured using Visual Analog Scale.
  • If being treated for upper limb pain - baseline Visual Analog Scale is ≥ 60 mm for upper limb pain
  • On stable (no change in dose, route, or frequency) prescribed pain medications being used for back and leg pain or upper limb pain, as determined by the investigator, for at least 28 days prior to device trial
  • Willing and able to provide signed and dated informed consent
  • Willing and able to comply with all study procedures and visits

排除标准

  • Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral Vascular Disease of Fontaine Stage III or higher
  • Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve stimulator, deep brain stimulator or an implantable intrathecal drug delivery system
  • Currently participating, or plans to participate, in another investigational study unless written approval is provided by the Medtronic study team
  • Major psychiatric comorbidity or other progressive diseases that may confound study results, as determined by the Investigator
  • Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance abuse), as determined by the Investigator
  • Pregnant or planning on becoming pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile, or be at least 2 years post-menopausal)
  • Be involved in an injury claim or under current litigation

结局指标

主要结局

Reduction in Overstimulation Sensation

时间窗: 30 days from device activation

The primary outcome is the proportion of low-back and/or leg pain subjects whose average overstimulation intensity score with Closed Loop On is less than their average overstimulation intensity score with Closed Loop Off. During in-clinic testing, subjects perform protocol prescribed activities and rate the intensity of the sensations on a 5-point Likert scale with both Closed Loop On and Off. The average overstimulation intensity scores within each subject are calculated separately for Closed Loop On and Off, and the proportion of subjects with a lower average overstimulation intensity score during Closed Loop On compared to their overstimulation intensity score during Closed Loop Off is calculated with a one-sided 97.5% lower bound.

次要结局

  • Responder Rate for Treatment of Overall Pain(3 months from device activation)
  • Responder Rate for Treatment of Low-back Pain(3 months from device activation)
  • Responder Rate for Treatment of Leg Pain(3 months from device activation)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验